Get the Stockscreener App
80.57
0.10%
0.08
After Hours:
80.99
0.42
+0.52%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $80.57, with a volume of 6.80M.
It is up +0.10% in the last 24 hours and up +7.08% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$80.49
Open:
$80.41
24h Volume:
6.80M
Relative Volume:
0.81
Market Cap:
$102.50B
Revenue:
$402.11B
Net Income/Loss:
$1.73B
P/E Ratio:
58.24
EPS:
1.3835
Net Cash Flow:
$7.81B
1W Performance:
+5.75%
1M Performance:
+7.08%
6M Performance:
+9.34%
1Y Performance:
+25.48%
1-Day Range:
$79.67
$81.09
1-Week Range:
$76.34
$81.69
52-Week Range:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, CNC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
80.57 | 102.40B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
UNH
Unitedhealth Group Inc
|
291.96 | 261.98B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CI
Cigna Group
|
284.74 | 74.81B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
291.45 | 62.69B | 199.13B | 5.66B | 3.17B | 25.11 |
|
CNC
Centene Corp
|
44.99 | 21.55B | 178.19B | 2.05B | 1.08B | 4.0447 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Tennessee Legislation Puts CVS Pharmacy Model And Valuation In Focus - simplywall.st
CVS Pharmacy is quietly changing how you get meds in the US - AD HOC NEWS
Price Over Earnings Overview: CVS Health - Benzinga
Truist Securities reiterates Buy rating on CVS Health stock at $98 - Investing.com South Africa
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS Health Corporation $CVS Shares Sold by South Dakota Investment Council - MarketBeat
CVS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CVS (CVS) EVP Samrat Khichi surrenders 7,886 shares for tax withholding - Stock Titan
CVS Health (CVS) CEO Joyner surrenders 1,944 shares for RSU tax withholding - Stock Titan
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Health and Aetna Celebrate the Grand Opening of Alta Vista at St. Joseph's Park in Rochester, NY - ACCESS Newswire
CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.78% Potential Upside in Healthcare - DirectorsTalk Interviews
How Is CVS Health’s Stock Performance Compared to Other Healthcare Stocks? - inkl
CVS Pharmacy just changed how you refill meds: here is what matters - AD HOC NEWS
How Investors May Respond To CVS Health (CVS) Facing Tennessee Crackdown On Its Integrated Pharmacy Model - Yahoo Finance
Glenview Capital Management Opens New $96 Million Position in DigitalOcean - The Motley Fool
Tounjian Advisory Partners LLC Makes New $1.28 Million Investment in CVS Health Corporation $CVS - MarketBeat
THE FRIDAY 5: CVS Employees Receive 42% Bonus Boost; Walgreens Cuts Over 600 Jobs - Progressive Grocer
Seattle Reign land CVS Health as new sponsorBizwomen - The Business Journals
10 best health insurance companies in the US - Insurance Business
Philly Says PBMs Can't Exit Suit Over Opioid Crisis - Law360
CVS corporate bonuses jump after 25% earnings spike - BenefitsPRO
CVS Health put volume heavy and directionally bearish - Yahoo Finance
CVS Caremark Advances Prior Authorization to Get Specialty Medications to Patients Faster - CVS Health
CVS Health Corp (CVS) Stock Price Down 4.79% on Feb 24 - GuruFocus
CVS slides as Medicare Advantage reimbursement outlook weighs on managed-care sentiment - Quiver Quantitative
CVS Significantly Increases Corporate Bonuses Following Record-High Annual Revenue - Progressive Grocer
CVS boosts employee bonuses after beating 2025 profit target - Health Leaders Media
Bearish Sentiment Surrounds CVS (CVS) Amid Active Options Tradin - GuruFocus
CVS employee bonuses surge after beating 2025 profit target - The Boston Globe
CVS Employee Bonuses Surge After Beating 2025 Profit Target - Bloomberg
Assessing CVS Health (NYSE:CVS) Valuation After Recent Share Pullback And Earnings Charges - Yahoo Finance
CVS Stock Quote Price and Forecast - CNN
Retirement Systems of Alabama's CVS Health Corp(CVS) Holding History - GuruFocus
CVS to pay $45M to resolve three lawsuits, AG says - WWLTV.com
Louisiana reaches $45M settlement with CVS Health, AG announces - Yahoo Finance
How CVS Health test-drives better care experiences using generative agents - CVS Health
HighTower Advisors LLC Has $20.08 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pharmacies and Healthcare Stores Market Report 2026-2035: A $1.73 Trillion Market by 2030 with Walgreens Boots Alliance, CVS Health, The Kroger Co, Rite Aid, Loblaw Companies Leading - Yahoo Finance
Seattle Reign land new sponsor ahead of 2026 season - The Business Journals
CVS goes all-in on women's soccer with multi-city field initiative - The Business Journals
Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits? - Finviz
CVS Health Links Pharmacy Scholarships To Valuation Gap And Equity Goals - Yahoo Finance
CVS Expands Support for Women's Soccer with New Partnerships and Investments - GuruFocus
CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness - Finviz
CVS Pharmacy community health partnership with U.S. Soccer and National Women's Soccer League - CVS Health
CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness – Company AnnouncementFT.com - Financial Times
Readystate Asset Management LP Makes New $1.43 Million Investment in CVS Health Corporation $CVS - MarketBeat
CVS will fund new community soccer fields with U.S. women’s league - Stock Titan
Millions of US Medicare Advantage enrollees forced to switch plans, study finds - Reuters
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):